Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone

Elsimar Metzker Coutinho, E M Coutinho
American Journal of Obstetrics and Gynecology · 1982 · vol. 144(8) , pp. 895–898 · doi:10.1016/0002-9378(82)90180-6 · PMID:6216812 · W1550067601
article OA: closed CC0 ⤵ 33 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper reports on the use of the synthetic antiestrogen, antiprogesterone gestrinone (R-2323), for the treatment of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Estrogen Antagonists Gestrinone Norpregnatrienes Progesterone Acne Vulgaris Acne Vulgaris Adult Dermatitis, Seborrheic Dermatitis, Seborrheic Endometriosis Endometriosis Estrogen Antagonists Female Gestrinone Gestrinone Humans Male Norpregnatrienes Pregnancy

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (16)

Cited by (33)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:10:00.881616+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK